Antigenic structure of poliovirus in inactivated vaccines

References

1. Beale A. J., Ungar J. 1962; Potency and stability of combined pertussis, diphtheria, tetanus and poliomyelitis (quadruple) vaccine. Lancet ii:805–808
   [Google Scholar]
2. Brioen P., Sijens R. J., Vrijsen R., Rombaut B., Thomas A. AM., Jackers A., Boeye A. 1982; Hybridoma antibodies to poliovirus N and H antigen. Archives of Virology 74:325–330
   [Google Scholar]
3. Ferguson M., Minor P. D. 1990; Differences in conformation of type 3 poliovirus antigenic sites on non-infectious empty particles and infectious virus. Journal of General Virology 71:1271–1274
   [Google Scholar]
4. Ferguson M., Minor P. D., Magrath D. I., Qui Y. FL., Spitz M., Schild G. C. 1984; Neutralization epitopes on poliovirus type 3 particles: an analysis using monoclonal antibodies. Journal of General Virology 65:197–201
   [Google Scholar]
5. Finney D. J. 1978 Statistical Methods in Biological Assay, 3rd edn. London: Griffin;
   [Google Scholar]
6. Kinnunen L., Hovi T. 1989; Partial RNA sequencing of eight supposed derivatives of type 3 poliovirus/USA/Saukett/50 reveals remarkable differences between three apparent substrains. Virology 170:316–320
   [Google Scholar]
7. Le Bouvier G. L. 1955; The modification of poliovirus antigens by heat and ultraviolet light. Lancet ii:1013–1016
   [Google Scholar]
8. Mayer M. M., Rapp FI. J, Roizman B., Klein S. W., Cowan K. M., Lukens D., Schwerdt C. E., Schaffer F. L., Charney J. 1957; The purification of poliomyelitis virus as studied by complement fixation. Journal of Immunology 78:435–155
   [Google Scholar]
9. Minor P. D. 1990; Antigenic structure of picornaviruses. Current Topics in Microbiology and Immunology 161:121–154
   [Google Scholar]
10. Minor P. D., Schild G. C., Wood J. M., Dandawate C. N. 1980; The preparation of specific immune sera against type 3 poliovirus D-antigen and C-antigen and the demonstration of two C-antigenic components in vaccine strain populations. Journal of General Virology 51:147–156
    [Google Scholar]
11. Minor P. D., Schild G. C., Ferguson M., Mackay A., Magrath D. I., John A., Yates P. J., Spitz M. 1982; Genetic and antigenic variation in type 3 polioviruses: characterization of strains by monoclonal antibodies and T1 oligonucleotide mapping. Journal of General Virology 61:167–176
    [Google Scholar]
12. Minor P. D., Ferguson M., Phillips A., Magrath D. I., Huovilainen A., Flovi T. 1987; Conservation in vivo of protease cleavage sites in antigenic sites of poliovirus. Journal of General Virology 68:1857–1865
    [Google Scholar]
13. Minor P. D., Ferguson M., Katrak K., Wood D., John A., Howlett J., Dunn G., Burke K., Almond J. W. 1991; Antigenic structure of chimeras of type 1 and type 3 poliovirus involving antigenic site 1. Journal of General Virology 71:2543–2551
    [Google Scholar]
14. Minor P. D., Ferguson M., Katrak K., Wood D., John A., Howlett J., Dunn G., Burke K., Almond J. W. 1991; Antigenic structure of chimeras of type 1 and type 3 polioviruses involving antigenic sites 2, 3 and 4. Journal of General Virology 72:2475–2481
    [Google Scholar]
15. Murdin A. D., Wimmer E. 1989; Construction of a poliovirus type 1/type 2 antigenic hybrid by manipulation of neutralization antigenic site II. Journal of Virology 63:5251–5257
    [Google Scholar]
16. Patel V., Ferguson M., Minor P. D. 1993; Antigenic sites in type 2 poliovirus. Virology 192:361–364
    [Google Scholar]
17. Singer C., Knauert F., Bushar G., Klutch M., Lundquist R., Quinnan G. V. Jr 1989; Quantitation of poliovirus antigens in inactivated viral vaccines by enzyme-linked immunosorbent assay using animal sera and monoclonal antibodies. Journal of Biological Standardization 17:137–150
    [Google Scholar]
18. Souvras M., Montagnon B., Fanget B., van Wezel A. L., Hazendonk A. G. 1980; Direct enzyme linked immunosorbent assay (ELISA) for quantification of poliomyelitis D-antigen. Developments in Biological Standardization 46:197–202
    [Google Scholar]
19. Uhlig H., Rutter G., Dernick R. 1983; Evidence for several unrelated neutralization epitopes of poliovirus, type 1, strain Mahoney, provided by neutralization tests and quantitative enzyme-linked immunosorbent assay (ELISA). Journal of General Virology 64:2809–2812
    [Google Scholar]
20. van der Marel P., Hazendonk A. G., van Wezel A. L. 1980; D antigen determination in polio vaccine production: comparison of gel diffusion and ELISA methods. Developments in Biological Standardization 47:101–108
    [Google Scholar]
21. van Ramshorst J. D., Polar M. F. 1966; The in vitro determination of the D antigens of poliomyelitis viruses. 1. The gel diffusion test. Immunology 11:297–311
    [Google Scholar]